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Background: The purpose of this study was to investigate the effect of hydroxypropyl methyl
cellulose phthalate (HPMCP) coating on the digestive stability and intestinal transport of
green tea catechins (GTCs).
Methods: Two types of HPMCP coatingwere prepared: one typewith size smaller than 500m
(S-HPMCP) and the other with size larger than 500m (L-HPMCP). An in vitro gastrointestinal
model system coupled with Caco-2 cells was used for estimating the bioavailability of GTCs.
Ultraperformance liquid chromatography with a photodiode array detector was performed
to analyze GTCs.
Results: The digestive stability of GTCs was enhanced up to 33.73% and 35.28% for S-HPMCP
and L-HPMCP, respectively. Intestinal transport of the GTCs was increased to 22.98% and
23.23% for S-HPMCP and L-HPMCP, respectively. Overall, the bioavailability of GTCs increased
by 4.08 and 11.71 times for S-HPMCP and L-HPMCP, respectively.intestinal transport Conclusion: The results of this study conﬁrm that coating with HPMCP could be a way to
improve the digestive stability and intestinal transport of GTCs.
© 2014 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license
1–41. IntroductionGreen tea is one of most popular beverages worldwide, and
it contains a series of polyphenols known as catechins.1
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Although green tea catechins (GTCs) provide a wide range of
beneﬁcial health effects, the oral bioavailability of catechinsnd Carbohydrate Bioproduct Research Center, Sejong University,
has been suggested to be low in humans. Differences in
pH levels and varying oxygen conditions during digestion are
major factors that degrade GTCs.5
vier. This is an open access article under the CC BY-NC-ND license
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An enteric coatingmaterial [i.e., hydroxypropylmethyl cel-
ulose phthalate (HPMCP)] has been used to protect drugs
r ﬂavonoids from degradation by gastric acid or to prevent
hem from causing side effects in the stomach.6,7 For example,
PMCP, frequently used as amatrix for oral dosage forms, was
xpected to enhance the bioavailability of ﬂavonoids, because
t has the ability to protect it from various levels of pH in the
astrointestinal tract of humans.8
Therefore, we aimed to examine the digestive stability and
ntestinal transport of catechins by coating themwith HPMCP.
. Methods
.1. Chemicals and standards
tandards of epigallocatechin, epigallocatechin gallate, epi-
atechin (EC), and epicatechin gallate were purchased from
ako (Osaka, Japan). Digestive enzymes (-amylase from
uman saliva, pepsin from porcine gastric mucosa, porcine
ipase, pancreatin from porcine pancreas, and bile extract
orcine) were obtained from Sigma-Aldrich (St. Louis, MO,
SA). High-performance liquid chromatography–grade sol-
ent of acetic acids, water, and methanol were obtained from
igma-Aldrich and J.T.Baker (Phillipsburg, NJ, USA).
.2. Sample preparation
wo types of HPMCP coating were prepared: one with a size
maller than 500m (S-HPMCP) and another type with a size
arger than 500m (L-HPMCP). The ratio of the catechin to
PMCP coating for L-HPMCP was 7:3 and for S-HPMCP it was
:8. The origin of catechin for the coating of S-HPMCP was
hina and that for the coating of L-HPMCP was Korea.
.3. Digestive stability of catechins using the in vitro
igestion model system
he method used in this study was designed by Lee et al.9
he in vitro digestion model system, including the human
astrointestinal tract, including salivary, gastric, and small
ntestinal phases, was simulated as described previously.5
pproximately 5mg of GTC and 5mg of HPMCP-coated GTCs
ere suspended in 5-mL aliquots of 20mM phosphate buffer.
or the salivary phase, 60L of -amylase (0.2mg/mL in 20mM
hosphate buffer) was added, and the initial pH was con-
rolled to 6.9 by adding 20mMphosphate buffer. Sampleswere
haken at a constant speed of 150 rpm in a shaking water bath
t a temperature of 37 ◦C for 5minutes. The gastric phase was
nitiated with 120L of porcine pepsin (3mg/mL in 100mM
odium bicarbonate solution), and the pH was maintained at
.0 by adding 0.1M hydrogen chloride. Solutions were then
ncubated in a shaking water bath for 30minutes, follow-
ng which a 0.1M solution of sodium bicarbonate was added
o neutralize the pH to 5.3. For the small intestinal phase,
he pH was regulated to 7.0 by adding 0.1M sodium hydrox-
de solution, followed by the addition of 60L pancreatic
nzyme mixture. The solution mixture was then incubated in
shaking water bath at 37 ◦C and 150 rpm for 1 hour. All sam-
les were brought to the ﬁnal volume of 5mL using 20mM35
phosphate buffer and a gentle stream of nitrogen gas was
passed in each step. Finally, the supernatant from the digesta
was obtained after centrifuging the solution mixture at 4 ◦C
and 3000 rpm for 30minutes for LCQ-Fleet ultraperformance
liquid chromatography using a photodiode array detector
(UPLC–PDA; Thermo Fisher Scientiﬁc, Waltham, MA, USA).
2.4. Observation of microscopy
The residues after continuous digestion were observed with
an optical microscope (CKX41, Olympus, Japan). The magniﬁ-
cation scale was 40×.
2.5. Study of intestinal transport of catechins using
Caco-2 human intestinal cell culture
Passage numbers 32–36 of the Caco-2 cell cultures were
obtained from the Korean Cell Line Bank (Seoul, South Korea)
for this study. A 12-transwell plate (Corning, NY, USA) was
used for Caco-2 cell cultures seeded in a growth medium con-
sisting of Dulbecco’s modiﬁed Eagle’s medium (DMEM; Gibco
Rockville, MD, USA) with 10% fetal bovine serum (FBS; Gibco,
NE, USA), 1% nonessential amino acid (Sigma), 1% penicillin
(Gibco), and 0.1% gentamicin (Gibco). The cells were main-
tained at 37 ◦C in an incubator with 5% CO2 and 95% air. A 10%
FBS-supplemented DMEM was used to change the medium of
the apical and basal compartments each day. Cellular trans-
port of catechins was assessed when the cells grew between 2
and 3weeks after being conﬂuent. The value of transepithelial
electric resistance (TEER) was measured by the Millicell ERS-2
system (Millipore, New Bedford, MA, USA) to ensure rigidity.
When the cells had a TEER value higher than 350, they were
used for the transport study. Each treatment mixture with a
basal cell culture medium was dispensed to the apical Caco-2
human intestinal cells, whichwere then incubated at 37 ◦C for
2hours. The basal medium was then collected for the liquid
chromatography–mass spectrometry analysis.
2.6. UPLC–PDA analysis
The method used for the UPLC–PDA analysis was designed
by Chung et al.5 The amount of catechins in the supernatant
after in vitro digestion and the transported amount of catechin
from the apical to basal compartment was quantiﬁed using
a UPLC–PDA/electrospray ionization/multistage mass spec-
trometry. Methanol was added into the collected supernatant
and basal media, and it was sonicated for 3minutes followed
by vortexing and centrifugation. The supernatant was ﬁltered
through a 0.45-mpolyvinyl diﬂuoride syringe ﬁlter (Millipore,
MA, USA) before the analysis. Chromatographic separation
was performed on a Hypersil GOLD C18 (2.1×50mm, 1.9m)
column with mobile phases of solvents A and B (vol:vol, 0.1%
acetic acid in water:methanol). A gradient elution was per-
formed by varying the proportion of solvents A and B with
a ﬂow rate of 200L/minute and with an initial phase of 5%
solvent B. The gradient increased linearly to 20% of solvent B
for 15minutes, increased linearly to 50% for next 5minutes,
and remained at 50% for 5minutes until injection of the next
sample for 10minutes. The injection volume was 2L. The
wavelength of the ultraviolet spectrum was set at 280nm.
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Figure 1 – Optical microscopic image of HPMCP coating for
GTCs after saliva–gastrointestinal digestion at a
magniﬁcation of 40×. (A) L-HPMCP; (B) S-HPMCP. HPMCP,
hydroxypropyl methyl cellulose phthalate; L-HPMCP,
Figure 2 – Digestive stability of the GTCs according to the
HPMCP coating size. S-HPMCP and L-HPMCP. There was
signiﬁcant difference between the treatment group and the
control group. Both S-HPMCP and L-HPMCP had
signiﬁcantly higher values than catechin (p < 0.05). GTC,
green tea catechin; HPMCP, hydroxypropyl methyl cellulose
phthalate; L-HPMCP, HPMCP size > 500m; S-HPMCP,
HPMCP size < 500m. The star shows the signiﬁcant
difference between control and treatment group.
Figure 3 – Small intestinal transport of the GTCs according
to the HPMCP coating size. S-HPMCP and L-HPMCP. There
was a signiﬁcant difference between the treatment group
and the control group. Both S-HPMCP and L-HPMCP had
signiﬁcantly higher values than catechin (p<0.05). GTC,
green tea catechin; HPMCP, hydroxypropyl methyl cellulose
phthalate; L-HPMCP, HPMCP size > 500m; S-HPMCP,
HPMCP size < 500m. The star shows the signiﬁcantHPMCP size > 500m; S-HPMCP, HPMCP size < 500m.
Chromatographic peaks and mass spectrums in the sam-
ples were identiﬁed using comparative retention times and
molecular weights of pure standards. Quantitative analysis
was conducted using a standard curve.
2.7. Statistical analysis
Values were reported as a mean ± standard deviation from
at least three different experiments. T-test was performed to
measure signiﬁcant differences between the control and treat-
ment groups at the signiﬁcant value p<0.05 using GraphPad
Prism 3.0 software (GraphPad, CA, USA).
3. Results
3.1. Disruption of HPMCP coating during digestion
Optical microscopy of HPMCP coating for GTCs after
saliva–gastrointestinal digestion is shown in Fig. 1. Regardless
of the HPMCP coating size, the surface of the HPMCP coating
was slightly ruptured after digestion.
3.2. Digestive stability of GTCs by HPMCP coating
The released amount of GTCs was 12.33% and 33.73% for
noncoated catechin and S-HPMCP, respectively. There was a
remarkable increase in the percentage of GTCs released in
catechin with L-HPMCP (Fig. 2). The digestive stability was
enhanced by 2.74 and 3.56 times for S-HPMCP and L-HPMCP,
respectively.
3.3. Intestinal transport of catechins by HPMCP
coating
The Caco-2 cell was used to evaluate intestinal transport of
GTCs using different sizes of HPMCP coating (Fig. 3). The
intestinal transport of GTCs without S-HPMCP coating was
15.36% and GTCswithout L-HPMCP coatingwas 6.70%, respec-
tively. Their treatment groups were 22.98% and 23.23% for
S-HPMCP and L-HPMCP, respectively. The increase in the
ratio of the intestinal transport of S-HPMCP and L-HPMCPdifference between control and treatment group.
was 1.50 times and 3.47 times, respectively. The intesti-
nal transport rate of L-HPMCP was better than S-HPMCP.
However, ultimately there were no signiﬁcant differences
between the S-HPMCP and L-HPMCP (p>0.05). Overall, the
estimated bioavailability of GTCs increased by 4.08 and 11.71
times for S-HPMCP and L-HPMCP, respectively.
4. DiscussionThe HPMCP is widely used as an enteric coating material in
the pharmaceutical industry as it is not dissolved in a gastric
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cid solution (pH ∼3); however, it is dissolved in an alkaline
nvironment such as that present in the small intestine (pH
–9).10 Therefore, coating with HPMCP may protect GTCs from
ifferent pH levels and oxygen exposure during digestion.
he GTCs were known to be affected by digestive enzymes,
ater activity, oxygen, and various pH values during diges-
ion. However, coating with HPMCP can protect GTCs from
igestive environments such as different pH values, activities
f various enzymes, and oxygen, thereby providing digestive
tability for the catechin.6,7,11 Among the catechins, EC has
een reported to show efﬂux pattern.5 However, HPMCP
rotects EC from the efﬂux in the small intestine by the efﬂux
rotein instead of changes in transport mechanisms.5,12 The
PMCP coating showed the efﬁciency in transport of GTCs
n the small intestine than catechin without HPMCP coating,
egardless of its size.
In conclusion, this study conﬁrmed that the HPMCP coat-
ng increased the digestive stability and intestinal transport of
TCs, resulting in enhancing bioavailability of the GTCs.
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